Literature DB >> 18037175

Potential of sponges and microalgae for marine biotechnology.

René H Wijffels1.   

Abstract

Marine organisms can be used to produce several novel products that have applications in new medical technologies, in food and feed ingredients and as biofuels. In this paper two examples are described: the development of marine drugs from sponges and the use of microalgae to produce bulk chemicals and biofuels. Many sponges produce bioactive compounds with important potential applications as medical drugs. Recent developments in metagenomics, in the culturing of associated microorganisms from sponges and in the development of sponge cell-lines have the potential to solve the issue of supply, which is the main limitation for sponge exploitation. For the production of microalgal products at larger scales and the production of biofuels, major technological breakthroughs need to be realized to increase the product yield.

Mesh:

Substances:

Year:  2007        PMID: 18037175     DOI: 10.1016/j.tibtech.2007.10.002

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  20 in total

1.  Maximum photosynthetic yield of green microalgae in photobioreactors.

Authors:  Jan-Willem F Zijffers; Klaske J Schippers; Ke Zheng; Marcel Janssen; Johannes Tramper; René H Wijffels
Journal:  Mar Biotechnol (NY)       Date:  2010-02-23       Impact factor: 3.619

2.  Micro- and nano-structural characterization of six marine sponges of the class Demospongiae.

Authors:  Elif Hilal Şen; Semra Ide; Sevgi Haman Bayari; Malcolm Hill
Journal:  Eur Biophys J       Date:  2016-04-11       Impact factor: 1.733

Review 3.  Microalgal cultivation for value-added products: a critical enviro-economical assessment.

Authors:  Richa Kothari; Arya Pandey; Shamshad Ahmad; Ashwani Kumar; Vinayak V Pathak; V V Tyagi
Journal:  3 Biotech       Date:  2017-07-14       Impact factor: 2.406

4.  Modeling lipid accumulation in oleaginous fungi in chemostat cultures: I. Development and validation of a chemostat model for Umbelopsis isabellina.

Authors:  Petra Meeuwse; Johannes Tramper; Arjen Rinzema
Journal:  Bioprocess Biosyst Eng       Date:  2011-05-03       Impact factor: 3.210

Review 5.  Antiviral lead compounds from marine sponges.

Authors:  Sunil Sagar; Mandeep Kaur; Kenneth P Minneman
Journal:  Mar Drugs       Date:  2010-10-11       Impact factor: 5.118

Review 6.  Microalgal Cell Biofactory-Therapeutic, Nutraceutical and Functional Food Applications.

Authors:  Boda Ravi Kiran; S Venkata Mohan
Journal:  Plants (Basel)       Date:  2021-04-21

Review 7.  Best practices in heterotrophic high-cell-density microalgal processes: achievements, potential and possible limitations.

Authors:  Fabian Bumbak; Stella Cook; Vilém Zachleder; Silas Hauser; Karin Kovar
Journal:  Appl Microbiol Biotechnol       Date:  2011-05-13       Impact factor: 4.813

Review 8.  Towards commercial production of sponge medicines.

Authors:  Marieke Koopmans; Dirk Martens; Rene H Wijffels
Journal:  Mar Drugs       Date:  2009-12-02       Impact factor: 5.118

Review 9.  Impact of marine drugs on animal reproductive processes.

Authors:  Francesco Silvestre; Elisabetta Tosti
Journal:  Mar Drugs       Date:  2009-11-06       Impact factor: 5.118

10.  Proximate Composition, Antioxidant Properties, and Hepatoprotective Activity of Three Species of Shellfish of the Pacific Coast of Russia.

Authors:  Ekaterina P Karaulova; Evgeny V Yakush; Tatiana N Slutskaya; Lidiya V Shulgina
Journal:  Molecules       Date:  2021-06-03       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.